Proteostasis Therapeutics Stumbles Despite Positive Early Stage Data
Proteostasis Therapeutics saw its shares slide early on Thursday after the company reported positive data from its early stage trial in cystic fibrosis.
All Work
Chris Lange
Why Five Below Is One of Thursday’s Big Earnings Winners
Five Below shares surged early Thursday after it released fiscal first-quarter financial results late on Wednesday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a positive day for the broad U.S. markets. The Nasdaq continued its streak and is closing at another record high. Crude oil backed off again dropping right at $65. The S&P 500…
Pfizer Drops $600 Million in Its Venture Capital Arm
Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a billion dollars to its venture capital arm.
How Amazon Is Breaking Into Fashion With Machine Learning
Amazon.com saw its shares up marginally on Wednesday after the company announced a new product in its Echo line, a virtual assistant to help users manage their closets and image better.
What the Management Picture for CVS and Aetna Will Look Like Going Forward
CVS Health and Aetna are closing in on finalizing the acquisition, and the companies have now announced the management team going forward.
Gold-Backed Inflows Rise in Asia and Europe
In the past month, global gold-backed exchange traded fund holdings added 15 tonnes. Ultimately, Europe and Asia drove inflows.
Why Axovant Shares More Than Doubled
Axovant Sciences shares more than doubled on Wednesday after the company announced a new licensing agreement.
Why Signet Jewelers’ Q1 Rocks
Signet Jewelers released better-than-expected fiscal first-quarter financial results before the markets opened on Wednesday.
Why Ambarella Shares Are Crumbling
Ambarella shares retreated early Wednesday after it released its fiscal first-quarter financial results late on Tuesday.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a mixed day for the broad U.S. markets. The Nasdaq continued its streak and is closing at another record high. Crude oil stopped the bleeding somewhat with a slight gain on the…
Verrica Pharmaceuticals Closes in on IPO
Verrica Pharmaceuticals expects to price 5 million shares in the range that results in an initial public offering valued up to $92 million.
Wedbush’s Monday ASCO Roundup
The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant moves we saw as a result.
Why Canaccord Genuity Is So Bullish on 2018
Canaccord Genuity has updated its Standard & Poor's 500 index target for 2018. What does the firm see for the second half of the year?
What’s Changed in the April JOLTS Report
The Bureau of Labor Statistics has issued its Job Openings and Labor Turnover Summary for the month of April.
Why Smartsheet Is Tuesday’s Big Earnings Winner
Smartsheet released better-than-expected fiscal first-quarter financial results after the markets closed on Monday.
How Deciphera Pharma Is Capitalizing Big on ASCO
Deciphera Pharmaceuticals saw its shares took a breather early Tuesday after the firm announced a secondary offering.
Mylan Wins Big With FDA Approval
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a solid day for the broad U.S. markets starting out the week with a gain. The Nasdaq closed at a record high, and for the first time above 7,600. Although, crude oil…
Consumers Finally Feeling Relief at the Pump
Oil prices continued their downward move from last week, paving the way for additional drops in gasoline prices in the near future.